
Semaglutide is a prescription GLP-1 receptor agonist generally administered once weekly to improve blood-sugar control in adults with type 2 diabetes. When combined with diet and physical activity, it may also reduce appetite and support weight loss during diabetes treatment.
| Generic Name | Semaglutide |
| Strength | 1 mg |
| Manufacturer | Sun Pharmaceutical |
| Packing | 2.0 pre-filled pens in 1 box |
| Prescribed For | Manage type 2 diabetes, support chronic weight management, and reduce cardiovascular risks or liver disease progression |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Semaglutide activates GLP-1 receptors in the body. It increases insulin release when glucose levels are high, reduces unnecessary glucagon production and slows digestion. This helps lower blood sugar and may increase feelings of fullness.
Dr. Rajiv Shah is a qualified medical professional with experience in diabetes care and the management of related metabolic conditions. His interests include personalised blood glucose control, medication management, glucose monitoring, nutrition, physical activity and long-term health support.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.